Intuitive Surgical - ISRG Stock Forecast, Price & News

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical Stock Down 0.9 %

Intuitive Surgical stock traded down $2.14 during trading hours on Friday, reaching $240.32. 1,861,078 shares of the company's stock were exchanged, compared to its average volume of 2,192,166. The firm's 50 day simple moving average is $212.55 and its 200 day simple moving average is $249.55. Intuitive Surgical has a twelve month low of $186.83 and a twelve month high of $369.69. The firm has a market capitalization of $85.82 billion, a PE ratio of 61.15, a PEG ratio of 6.50 and a beta of 1.29.

Intuitive Surgical (NASDAQ:ISRG - Get Rating) last issued its quarterly earnings results on Thursday, July 21st. The medical equipment provider reported $1.14 earnings per share for the quarter, topping analysts' consensus estimates of $1.01 by $0.13. Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. During the same quarter in the prior year, the company posted $1.42 earnings per share. Analysts anticipate that Intuitive Surgical will post 3.76 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. The Goldman Sachs Group dropped their target price on shares of Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating for the company in a report on Friday, July 29th. BTIG Research dropped their target price on shares of Intuitive Surgical from $355.00 to $247.00 and set a "buy" rating for the company in a report on Monday, July 18th. Evercore ISI dropped their target price on shares of Intuitive Surgical from $210.00 to $175.00 in a report on Friday, July 22nd. Stifel Nicolaus dropped their target price on shares of Intuitive Surgical from $325.00 to $270.00 in a report on Monday, July 18th. Finally, Raymond James dropped their target price on shares of Intuitive Surgical from $294.00 to $255.00 in a report on Friday, July 22nd. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus price target of $273.23.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction dated Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now directly owns 11,224 shares in the company, valued at approximately $2,671,760.96. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Amal M. Johnson sold 6,375 shares of the firm's stock in a transaction dated Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total value of $1,517,505.00. Following the completion of the sale, the director now directly owns 11,224 shares in the company, valued at approximately $2,671,760.96. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Myriam Curet sold 9,000 shares of the firm's stock in a transaction dated Wednesday, July 27th. The shares were sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the sale, the executive vice president now owns 217 shares of the company's stock, valued at $48,825. The disclosure for this sale can be found here. In the last ninety days, insiders sold 94,787 shares of company stock worth $20,719,321. Company insiders own 0.90% of the company's stock.